BAX logo

Baxter International (BAX) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

27 October 1981

Indexes:

Description:

Baxter International Inc. through its subsidiaries develops and provides a wide portfolio of medical products. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. The company offers the following products and solutions: systems for dialysis therapy (peritoneal dialysis and hemodialysis), sterile intravenous solutions, infusion systems and devices, parenteral nutrition, inhalation anesthetics, and universal injectable pharmaceuticals. Baxter International also provides biological products and medical devices, surgical hemostats and sealants used in surgical procedures for hemostasis, tissue sealing, and prevention of adhesion.

Key Details

Price

$29.10

TTM Dividend Yield

3.57%(+18.60% YoY)

PE Ratio

145.50(+1871.54% YoY)

Beta

0.46

Events Calendar

Earnings

Next earnings date:

Feb 07, 2025

Recent quarterly earnings:

Nov 08, 2024

Recent annual earnings:

Feb 08, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Nov 29, 2024
Splits

Next split:

N/A

Recent split:

July 01, 2015

Analyst ratings

Recent major analysts updates

11 Dec '24 Citigroup
Neutral
11 Nov '24 Stifel
Buy
01 Oct '24 Citigroup
Neutral
08 Aug '24 Goldman Sachs
Neutral
07 Aug '24 Wells Fargo
Equal-Weight
07 Aug '24 JP Morgan
Neutral
15 July '24 Morgan Stanley
Underweight
11 July '24 Citigroup
Neutral
02 July '24 Evercore ISI Group
Outperform
30 May '24 Goldman Sachs
Neutral

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Baxter Stock May Gain Following Five New Injectable Product Launches
Baxter Stock May Gain Following Five New Injectable Product Launches
Baxter Stock May Gain Following Five New Injectable Product Launches
BAX
zacks.com13 December 2024

BAX has introduced five new injectable products in the United States, which enhances its pharmaceutical business in the country. This move helps to solidify BAX's presence in the U.S. market.

Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?
Is the Options Market Predicting a Spike in Baxter International (BAX) Stock?
BAX
zacks.com10 December 2024

Investors should closely monitor Baxter International (BAX) stock due to recent changes in the options market.

Baxter resumes dialysis solution production at its hurricane-hit facility
Baxter resumes dialysis solution production at its hurricane-hit facility
Baxter resumes dialysis solution production at its hurricane-hit facility
BAX
reuters.com05 December 2024

On Thursday, Baxter International announced that it has restarted production on all dialysis solution manufacturing lines at its North Carolina plant, which had been affected by flooding from a hurricane.

Baxter Declares Quarterly Dividend
Baxter Declares Quarterly Dividend
Baxter Declares Quarterly Dividend
BAX
businesswire.com11 November 2024

Baxter International Inc., a leading global medical technology company, has announced a quarterly cash dividend of $0.17 per share of common stock. This dividend will be paid on January 2, 2025, to shareholders who are on record as of November 29, 2024. The annual dividend rate is set at $0.68 per share, reflecting the company's new quarterly rate ahead of the sale of its Kidney Care business.

BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline
BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline
BAX Stock Falls Despite Q3 Earnings & Sales Beat, Margins Decline
BAX
zacks.com08 November 2024

Baxter has announced third-quarter results that are better than anticipated. However, the company's gross and operating margins have decreased.

Baxter International (BAX) Beats Q3 Earnings Estimates
Baxter International (BAX) Beats Q3 Earnings Estimates
Baxter International (BAX) Beats Q3 Earnings Estimates
BAX
zacks.com08 November 2024

Baxter International (BAX) reported quarterly earnings of $0.80 per share, which is higher than the Zacks Consensus Estimate of $0.78 per share. This is an increase compared to earnings of $0.68 per share from the same period last year.

Baxter cuts annual profit forecast on hurricane impact
Baxter cuts annual profit forecast on hurricane impact
Baxter cuts annual profit forecast on hurricane impact
BAX
reuters.com08 November 2024

On Friday, Baxter International lowered its yearly profit expectations because its intravenous solutions plant was affected by a hurricane, causing its stock to drop by 3.3% in early trading.

Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript
Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript
Baxter International Inc. (BAX) Q3 2024 Earnings Call Transcript
BAX
seekingalpha.com08 November 2024

Baxter International Inc. (NYSE:BAX) will hold its Q3 2024 Earnings Conference Call on November 8, 2024, at 8:30 AM ET. The call will feature company leaders, including Clare Trachtman, Joe Almeida, and Joel Grade, along with participants from various financial institutions. Attendees will be in listen-only mode until the question-and-answer portion begins.

Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings
Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings
Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings
BAX
zacks.com06 November 2024

BAX's results for the third quarter are expected to improve due to favorable pricing and the introduction of new products. On the other hand, supply chain problems may have increased costs during this period.

Countdown to Baxter (BAX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Countdown to Baxter (BAX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Countdown to Baxter (BAX) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
BAX
zacks.com05 November 2024

Assess Baxter's (BAX) anticipated performance for the quarter that ended in September 2024 by going beyond the usual Wall Street revenue and profit predictions. Instead, focus on some important metrics to gain a clearer understanding of the company's outlook.

FAQ

  • What is the primary business of Baxter International?
  • What is the ticker symbol for Baxter International?
  • Does Baxter International pay dividends?
  • What sector is Baxter International in?
  • What industry is Baxter International in?
  • What country is Baxter International based in?
  • When did Baxter International go public?
  • Is Baxter International in the S&P 500?
  • Is Baxter International in the NASDAQ 100?
  • Is Baxter International in the Dow Jones?
  • When was Baxter International's last earnings report?
  • When does Baxter International report earnings?
  • Should I buy Baxter International stock now?

What is the primary business of Baxter International?

Baxter International Inc. through its subsidiaries develops and provides a wide portfolio of medical products. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois. The company offers the following products and solutions: systems for dialysis therapy (peritoneal dialysis and hemodialysis), sterile intravenous solutions, infusion systems and devices, parenteral nutrition, inhalation anesthetics, and universal injectable pharmaceuticals. Baxter International also provides biological products and medical devices, surgical hemostats and sealants used in surgical procedures for hemostasis, tissue sealing, and prevention of adhesion.

What is the ticker symbol for Baxter International?

The ticker symbol for Baxter International is NYSE:BAX

Does Baxter International pay dividends?

Yes, Baxter International pays dividends. The last payment was $0.17, with an ex-dividend date on 29 November 2024

What sector is Baxter International in?

Baxter International is in the Healthcare sector

What industry is Baxter International in?

Baxter International is in the Medical Instruments & Supplies industry

What country is Baxter International based in?

Baxter International is headquartered in United States

When did Baxter International go public?

Baxter International's initial public offering (IPO) was on 27 October 1981

Is Baxter International in the S&P 500?

Yes, Baxter International is included in the S&P 500 index

Is Baxter International in the NASDAQ 100?

No, Baxter International is not included in the NASDAQ 100 index

Is Baxter International in the Dow Jones?

No, Baxter International is not included in the Dow Jones index

When was Baxter International's last earnings report?

Baxter International's most recent earnings report was on 8 November 2024

When does Baxter International report earnings?

The next expected earnings date for Baxter International is 7 February 2025

Should I buy Baxter International stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions